seizing the mkt opportunity/ current mkt conditions in the usa is a good example, page-4

I get what you're saying but I don't think it's very wise to twist their arm into a massive increase.

If Merck sell what is essentially the same product for 600-800 dollars per 10 mil, why would Ellume want to pay 12.5-25x more?

It does enable their product, but having them pay so much more I don't think is realistic, unless Ellume want to be generous. But they are a business at the end of the day. And forcing them to pay a high price could push them to seek alternatives in future products.

I just don't see it happening. I certainly hope that I'm wrong though. I'm all for more money for ADO.